[Adverse cardiac effects associated with anticancer drugs]. / Syöpälääkkeiden sydänhaitat.
Duodecim
; 131(5): 441-7, 2015.
Article
em Fi
| MEDLINE
| ID: mdl-26237906
ABSTRACT
With the development of new protein kinases, antibodies, immunomodulators and hormonal treatments, significant progress has taken place in the last few years in the pharmacological treatment of cancers. At the same time, old cytotoxic drugs still remain in use. In regard to the heart, anthracyclines are the most problematic cytotoxic drugs, as they may cause cardiac insufficiency that is manifested only years after the treatment. Also trastuzumab and kinase inhibitors may cause cardiac insufficiency. Fluoropyrimidines cause myocardial ischemia for some patients. Treatments targeting VEGF inhibition are frequently associated with significant elevation of blood pressure.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Coração
/
Cardiopatias
/
Neoplasias
/
Antineoplásicos
Tipo de estudo:
Etiology_studies
/
Risk_factors_studies
Limite:
Humans
Idioma:
Fi
Ano de publicação:
2015
Tipo de documento:
Article